Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE51.451.6 (+3.21 %)
PREV CLOSE ( ) 49.85
OPEN PRICE ( ) 51.90
BID PRICE (QTY) 51.20 (969)
OFFER PRICE (QTY) 51.40 (1044)
VOLUME 71029
TODAY'S LOW / HIGH ( )51.30 52.30
52 WK LOW / HIGH ( )9.9 57.1
NSE51.801.95 (+3.91 %)
PREV CLOSE( ) 49.85
OPEN PRICE ( ) 51.80
BID PRICE (QTY) 51.50 (1500)
OFFER PRICE (QTY) 51.80 (17039)
VOLUME 63136
TODAY'S LOW / HIGH( ) 51.80 51.80
52 WK LOW / HIGH ( )9.85 57.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email companysecretary@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

08Jun Marksans Pharma recalls one batch of M
Marksans Pharma has issued voluntary recall of one batch of Metformin Ex..
08Jun Marksans Pharma gains on recalling one
Marksans Pharma is currently trading at Rs. 32.45, up by 0.65 points or..
11Feb Marksans Pharma receives EIR from USFD
Marksans Pharma has received Establishment Inspection Report (EIR) from..
11Feb Marksans Pharma shines on receiving EI
Marksans Pharma is currently trading at Rs. 23.10, up by 1.00 points or..
14Jan Marksans Pharma informs about certific
Marksans Pharma has informed that the Company enclosed a Certificate und..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit220.56379.03
Gross Profit 249.21 527.27
Operating Profit 290.52716.63
Net Sales 1559.594334.15

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  16449.30 (0.78%)
M.Cap ( in Cr)34682.47
Procter&Gamble Healt (BSE)
peergroup  5097.10 (1.59%)
M.Cap ( in Cr)8328.82
Alkem Laboratories (BSE)
peergroup  2796.05 (0.87%)
M.Cap ( in Cr)33142.22
Torrent Pharma (BSE)
peergroup  2716.35 (0.87%)
M.Cap ( in Cr)45566.22
Piramal Enterprises (BSE)
peergroup  1306.20 (1.74%)
M.Cap ( in Cr)28956.86

Shareholding Pattern

PROMOTERS 48.25%
NON-INSTITUTION 47.8%
FI/BANKS/INSURANCE 0.43%
FII 0.2%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%

Mf Holdings

Scheme NameHold(%)
GS CNX 500(G)0.02

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 49.85. Its current market capitalisation stands at Rs 2040.43 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11342.09 Cr and Total Income of Rs.11345.37 Cr. The company's management includes Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)